Attention-deficit/hyperactivity disorder among children and adolescents in the United States: Trend in diagnosis and use of pharmacotherapy by gender

Clinical Pediatrics

Volumn 51, Issue 6, 2012, Pages 584-589

  Sclar, David A ^a,b   Robison, Linda M ^a   Bowen, Kurt A ^a   Schmidt, Jennifer M ^a   Castillo, Leigh V ^a   Oganov, Ambartsum M ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b Washington Institute for Mental Illness Research and Training   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATOMOXETINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CLINICAL PRACTICE; CONSULTATION; DATA ANALYSIS; FEMALE; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; SEX DIFFERENCE; TREND STUDY; UNITED STATES;

ADOLESCENT; ADRENERGIC UPTAKE INHIBITORS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; PROPYLAMINES; SEX DISTRIBUTION; UNITED STATES;

EID: 84861174166     PISSN: 00099228     EISSN: 19382707     Source Type: Journal    
DOI: 10.1177/0009922812439621     Document Type: Article

References (37)

1. Barkley RA, Fischer M, Smallish L, Fletcher K. The persistence of attention-deficit/hyperactivity disorder into young adulthood as a function of reporting source and definition of disorder. J Abnorm Psychol. 2002 ; 111: 279-289 (Pubitemid 34441206)
2. Kessler RC, Adler L, Barkley R, et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006 ; 163: 716-723 (Pubitemid 44464584)
3. Froehlich TE, Lanphear BP, Epstein JN, Barbaresi WJ, Katusic SK, Kahn RS. Prevalence, recognition, and treatment of attention-deficit/hyperactivity disorder in a national sample of US children. Arch Pediatr Adolesc Med. 2007 ; 161: 857-864 (Pubitemid 47360887)
4. Robison LM, Skaer TL, Sclar DA. Is attention-deficit hyperactivity disorder (ADHD) diagnosed in adults?. Int J Pharm Med. 2004 ; 18: 337-341
5. Robison LM, Sclar DA, Skaer TL, Galin RS. National trends in the prevalence of attention-deficit/hyperactivity disorder and the prescribing of methylphenidate among school-age children: 1990-1995. Clin Pediatr (Phila). 1999 ; 38: 209-217 (Pubitemid 29186373)
6. Biederman J, Faraone SV. The Massachusetts General Hospital studies of gender influences on attention-deficit/hyperactivity disorder in youth and relatives. Psychiatr Clin North Am. 2004 ; 27: 225-232 (Pubitemid 38452765)
7. Derks EM, Hudziak JJ, Boomsma DI. Why more boys than girls with ADHD receive treatment: a study of Dutch twins. Twin Res Hum Genet. 2007 ; 10: 765-770 (Pubitemid 47608011)
8. Biederman J, Mick E, Faraone SV, et al. Influence of gender on attention deficit hyperactivity disorder in children referred to a psychiatric clinic. Am J Psychiatry. 2002 ; 159: 36-42 (Pubitemid 41070724)
9. Novik TS, Hervas A, Ralston SJ, et al. Influence of gender on attention-deficit/hyperactivity disorder in Europe-ADORE. Eur Child Adolesc Psychiatry. 2009 ; 18: 194-196
10. Bauermeister JJ, Shrout PE, Chávez L, et al. ADHD and gender: are risks and sequela of ADHD the same for boys and girls?. J Child Psychol Psychiatry. 2007 ; 48: 831-839 (Pubitemid 47226288)
11. Clinical practice guideline: diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. Pediatrics. 2000 ; 105: 1158-1170
12. Pliszka S. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2007 ; 46: 894-921
13. Wolraich ML, Wibbelsman CJ, Brown TE, et al. Attention-deficit/ hyperactivity disorder among adolescents: a review of the diagnosis, treatment, and clinical implications. Pediatrics. 2005 ; 115: 1734-1746 (Pubitemid 43843185)
14. Winterstein AG, Gerhard T, Shuster J, et al. Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database. Ann Pharmacother. 2008 ; 42: 24-31
15. Visser SN, Lesesne CA, Perou R. National estimates and factors associated with medication treatment for childhood attention-deficit/hyperactivity disorder. Pediatrics. 2007 ; 119: S99 - S106
16. Castle L, Aubert RE, Verbrugge RR, Khalid M, Epstein RS. Trends in medication treatment for ADHD. J Atten Disord. 2007 ; 10: 335-342
17. Olfson M, Marcus SC, Weissman MM, Jensen PS. National trends in the use of psychotropic medications by children. J Am Acad Child Adolesc Psychiatry. 2002 ; 41: 514-521 (Pubitemid 38338129)
18. Olfson M, Gameroff MH, Marcus SC, Jensen PS. National trends in the treatment of attention deficit hyperactivity disorder. Am J Psychiatry. 2003 ; 160: 1071-1077 (Pubitemid 41070965)
19. Zuvekas SH, Vitiello B, Norquist GS. Recent trends in stimulant medication use among U.S. children. Am J Psychiatry. 2006 ; 163: 579-585 (Pubitemid 44464565)
20. Guevara J, Lozano P, Wickizer T, Mell L, Gephart H. Psychotropic medication use in a population of children who have attention-deficit/ hyperactivity disorder. Pediatrics. 2002 ; 109: 733-739 (Pubitemid 34493335)
21. Dopheide JA, Pliszka SR. Attention-deficit-hyperactivity disorder: an update. Pharmacotherapy. 2009 ; 29: 656-679
22. Robison LM, Skaer TL, Sclar DA, Galin RS. Is attention deficit hyperactivity disorder increasing among girls in the US?. CNS Drugs. 2002 ; 16: 129-137
23. National Center for Health Statistics. National Ambulatory Medical Care Surveys, 1991-2008. http//: www.cdc.gov/nchs/about/major/ahcd/ahcd1.htmAccessed February 7, 2012.
24. Bryant E, Shimizu I. Sampling design, sampling variance, and estimation procedures for the National Ambulatory Medical Care Survey. Vital Health Stat 2. 1988 ; 108: 1-39
25. International Classification of Diseases, 9th Revision, Clinical Modification, Vol. 1. Washington, DC: Public Health Service ; 1989:
26. National Drug Code Directory, 1995 edition. Washington DC: Public Health Service ; 1995:
27. Cerner Multum, Inc. Lexicon. http://www.multum.com/Lexicon.htm. Accessed November 12, 2011.
28. Robison LM, Skaer TL, Sclar DA. Trends in ADHD and stimulant use among adults: 1995-2002. Psychiatr Serv. 2005 1497 ; 56:
29. Sclar DA, Robison LM, Skaer TL. Ethnicity/race and the diagnosis of depression and use of antidepressants by adults in the United States. Int Clin Psychopharmacol. 2008 ; 23: 106-109 (Pubitemid 351317283)
30. Skaer TL, Sclar DA, Robison LM. Trends in prescriptions for antidepressant pharmacotherapy among U.S. children and adolescents diagnosed with depression: an assessment of accordance with treatment recommendations from the American Academy of Child and Adolescent Psychiatry. Clin Ther. 2009 ; 31: 1478-1487
31. US Census Bureau. National population estimates for the 1990s. Monthly postcensal resident population, by single year of age, sex, race, and Hispanic origin. Washington, DC: Population Estimates Program Population Division. http://www.census.gov/popest/data/national/asrh/1990s/nat-monthly-resident.html. Accessed November 12, 2011.
32. US Census Bureau. National population estimates: characteristics. National sex, age, race and Hispanic origin: April 1, 2000 to July 1, 2008. Washington, DC: Population Estimates Program Population Division. http://www.census.gov/popest/data/historical/2000s/vintage-2008/index.html. Accessed November 12, 2011.
33. Faraone SV, Biederman J, Mick E, et al. A family study of psychiatric comorbidity in girls and boys with attention-deficit/hyperactivity disorder. Biol Psychiatry. 2001 ; 50: 586-592 (Pubitemid 33022643)
34. Barbaresi WJ, Katusic SK, Colligan RC, Weaver AL, Leibson CL, Jacobsen SJ. Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder: results from a population-based study. J Dev Behav Pediatr. 2006 ; 27: 1-10 (Pubitemid 44315107)
35. Leutwyler K. Paying attention. The controversy over ADHD and the drug Ritalin is obscuring a real look at the disorder and its underpinnings. Sci Am. 1996 ; 275: 12-14
36. Safer DJ. Are stimulants overprescribed for youths with ADHD?. Ann Clin Psychiatry. 2000 ; 12: 55-62 (Pubitemid 30217814)
37. Spencer TH, Biederman J, Mick E. Attention-deficit/hyperactivity disorder: diagnosis, lifespan, comorbidities, and neurobiology. J Pediatr Psychol. 2007 ; 32: 631-642